Methyl Jasmonate

Methyl Jasmonate

SCHEMBL2496795

CC/C=C/CC1C(=O)CCC1CC(=O)OC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.72
AKR1C3 P42330 1/20 0.72
AKR1C2 P52895 1/20 0.72
PTGER2 P43116 6/20 0.40
PTGER4 P35408 3/20 0.40
PTGER3 P43115 3/20 0.40
HTT P42858 1/20 0.37
BRD4 O60885 1/20 0.33
OXER1 Q8TDS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Jasmonate SCHEMBL1301885 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL5964117 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL14446196 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL36184 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl-7-Epi-Jasmonate SCHEMBL1302100 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL23196389 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL18853816 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL14446250 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL1302102 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4
Methyl Jasmonate SCHEMBL1301883 1.00 AKR1C4 (0.72) AKR1C4AKR1C3AKR1C2PTGER2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295123-A1 Arthropod Control Compositions FIRMENICH & CIE (CH) 2025-09-25 US claimed
EP-4583708-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2025-07-16 EP claimed
US-20250143297-A1 Arthropod Control Compositions FIRMENICH SA (CH) 2025-05-08 US claimed
US-20250113823-A1 Arthropod Control Compositions FIRMENICH SA (CH) 2025-04-10 US claimed
EP-4447678-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2024-10-23 EP claimed
EP-4444095-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2024-10-16 EP claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 US claimed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 EP claimed
WO-2024084006-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2024-04-25 WO claimed
US-20230247992-A1 ARTHROPOD CONTROL COMPOSITION FIRMENICH & CIE (CH) 2023-08-10 US claimed
WO-2022013204-A1 ARTHROPOD CONTROL COMPOSITION FIRMENICH SA (CH) 2022-01-20 WO claimed
CN-112638861-A Process for preparing cis-alpha, beta-substituted cyclopentanones 弗门尼舍有限公司 2021-04-09 CN claimed
WO-2019055408-A1 FORMULATIONS FOR KILLING BITING ARTHROPODS BEDOUKIAN RESEARCH, INC. (US) 2019-03-21 WO claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
EP-3353272-A1 PERFUME COMPOSITIONS Givaudan SA (CH) 2018-08-01 EP claimed
US-20180187123-A1 Perfume Compositions GIVAUDAN S.A. (CH) 2018-07-05 US claimed
WO-2017050971-A1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2017-03-30 WO claimed
EP-2846636-A1 CONTROL AND REPELLENCY OF BITING FLIES, HOUSE FLIES, TICKS, ANTS, FLEAS, BITING MIDGES, COCKROACHES, SPIDERS AND STINK BUGS Bedoukian Research, Inc. (US) 2015-03-18 EP claimed
WO-2013165479-A1 CONTROL AND REPELLENCY OF BITING FLIES, HOUSE FLIES, TICKS, ANTS, FLEAS, BITING MIDGES, COCKROACHES, SPIDERS AND STINK BUGS BEDOUKIAN RESEARCH, INC. (US) 2013-11-07 WO claimed
US-8551510-B2 Bed bug control and repellency BEDOUKIAN RESEARCH, INC. (US) 2013-10-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250143297-A1 Arthropod Control Compositions AGO2, EXOSC9, C5 AKR1C4 2456/4885AKR1C3 2273/4885AKR1C2 2892/4885
US-20250113823-A1 Arthropod Control Compositions AGO2, EXOSC9, C5 AKR1C4 2456/4885AKR1C3 2273/4885AKR1C2 2892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.